Asarfi Hospital Reports Record Sales Amid Rising Interest Expenses Challenges

Asarfi Hospital has recently undergone a financial trend adjustment, reflecting a notable performance in its latest quarterly results for September 2025. The company reported its highest net sales at Rs 44.89 crore, alongside a peak in PBDIT at Rs 8.87 crore. Profit before tax, excluding other income, reached Rs 4.89 crore, while the profit after tax stood at Rs 4.20 crore. The earnings per share also hit a record high of Rs 2.13, indicating strong operational efficiency. However, the company faces challenges with interest expenses, which have grown significantly to Rs 3.64 crore, marking an increase of 32.85% over the past nine months. This rise in interest costs could impact overall profitability if not managed effectively. In terms of market performance, Asarfi Hospital has outperformed the Sensex over various time frames. Over the past week, the stock returned 6.73%, while the Sensex saw a slight decline of 0.25%. In the last month, Asarfi Hospital's stock surged by 21.7%, compared to a modest 0.91% gain for the Sensex. Year-to-date, the company has achieved a remarkable return of 53.1%, significantly outpacing the Sensex's 6.54%. Over the past year, Asarfi Hospital's stock has risen by 72.06%, further highlighting its strong market position.